Matches in Ubergraph for { <http://purl.obolibrary.org/obo/NCIT_C15478> ?p ?o ?g. }
Showing items 1 to 19 of
19
with 100 items per page.
- NCIT_C15478 IAO_0000115 "A means for providing compassionate use of investigational agents between the time that an agent has been shown to have anti-tumor activity and the time that drug becomes available on the market. Investigational agents that have been given Group C/Treatment IND designation by the FDA have reproducible efficacy in one or more specific tumor types. Such an agent is likely to alter the pattern of treatment of the disease and can be safely administered by properly trained physicians without specialized supportive care facilities. If a drug meets these criteria CTEP may initiate a formal application to the FDA to authorize Group C distribution for a specific indication. Such approval is not equivalent to formal FDA approval of effectiveness for this indication. Any registered investigator may receive a Group C agent." @default.
- NCIT_C15478 NCIT_NHC0 "C15478" @default.
- NCIT_C15478 NCIT_P106 "Intellectual Product" @default.
- NCIT_C15478 NCIT_P108 "Group C/Treatment IND Protocol" @default.
- NCIT_C15478 NCIT_P207 "C1512278" @default.
- NCIT_C15478 NCIT_P366 "Group_C_Treatment_IND_Protocol" @default.
- NCIT_C15478 normalizedInformationContent "100" @default.
- NCIT_C15478 referenceCount "1" @default.
- NCIT_C15478 hasExactSynonym "Group C/Treatment IND Protocol" @default.
- NCIT_C15478 hasExactSynonym "Treatment IND Protocol, Group C" @default.
- NCIT_C15478 type Class @default.
- NCIT_C15478 isDefinedBy ncit.owl @default.
- NCIT_C15478 label "Group C/Treatment IND Protocol" @default.
- NCIT_C15478 subClassOf NCIT_C15478 @default.
- NCIT_C15478 subClassOf NCIT_C19498 @default.
- NCIT_C15478 subClassOf NCIT_C20181 @default.
- NCIT_C15478 subClassOf NCIT_C25198 @default.
- NCIT_C15478 subClassOf NCIT_C42651 @default.
- NCIT_C15478 subClassOf NCIT_C97331 @default.